18. November 2009 09:14
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric (stomach) cancer.
[More]
22d7d56a-040a-4b79-b687-06869cbedf35|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Anemia, Cancer, Cell, Chemotherapy, Doxorubicin, Dysplasia, Epirubicin, Gastritis, Helicobacter pylori Infection, Investment, Leukemia, Oncology, Smoking, Stomach Cancer, Tobacco
15. October 2009 04:54
An incisionless operation to patch stomach ulcers and potentially other perforations in the digestive tract may soon move into human trials at the Mayo Clinic in Rochester, MN. Clinical investigators reported on their research experience at the 95th annual Clinical Congress of the American College of Surgeons.
[More]
14. October 2009 06:37
A special protein in the lining of the stomach has been shown to be an important part of the body's defense against the stomach ulcer bacterium Helicobacter pylori in a new study from the Sahlgrenska Academy at the University of Gothenburg. The discovery may explain why the bacterium makes some people more ill than others.
[More]
12. October 2009 05:43
A special protein in the lining of the stomach has been shown to be an important part of the body's defence against the stomach ulcer bacterium Helicobacter pylori in a new study from the Sahlgrenska Academy at the University of Gothenburg. The discovery may explain why the bacterium makes some people more ill than others.
[More]
25. September 2009 04:28
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The report covers both currently marketed and late stage development cancer products. Revenues for each current market segment were generated using dollar and unit sales for each product.
[More]
0651d78e-34af-436d-ae14-022935085327|0|.0
Posted in: Medical Condition News
Tags: Alimta, Antisense, Apoptosis, Avastin, Bevacizumab, Biochemistry, Bladder Cancer, Breast Cancer, Cancer, Cervical Cancer, Cetuximab, Chemotherapy, Colorectal Cancer, DNA, Esophageal Cancer, Estrogen, Gemzar, Gleevec, Gonadotropin, Investment, Iressa, Leukemia, Life Expectancy, Lung Cancer, Lymphoma, MabThera, Melanoma, Metabolism, Multiple Myeloma, Neuroblastoma, Obesity, Oligonucleotides, Ovarian Cancer, Pfizer, Pharmacogenomics, Prostate Cancer, Radiation Therapy, Rituximab, Sprycel, Stomach Cancer, Tarceva, Taxol, Taxotere, Vectibix, Xeloda, Zolinza
17. September 2009 04:25
But not all the news about ovarian cancer is grim. Incidence is declining. Doctors are learning more about early symptoms and more effective treatments. The September issue of Mayo Clinic Women's HealthSource looks at myths and facts about ovarian cancer.
[More]
c542598e-4a43-48c6-9a54-e8fd1bd370a3|0|.0
Posted in: Women's Health News
Tags: Blood Pressure, Breast Cancer, Cancer, Cervical Cancer, Chemotherapy, Diet, Exercise, Hysterectomy, Obesity, Osteoporosis, Ovarian Cancer, Stomach Cancer, Stroke, Tai Chi, Ultrasound, Yoga
15. September 2009 01:19
Reducing sodium intake is a major public health priority that must be acted upon by governments and nongovernmental organizations to improve population health, states an article http://www.cmaj.ca/press/cmaj090361.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.
[More]
13. August 2009 00:43

A team of researchers from Boston University, Harvard Medical School and Massachusetts Institute of Technology recently made a discovery that changes a long held paradigm about how bacteria move through soft gels.
[More]
12. August 2009 04:12
Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published (Wednesday) in the British Journal of Cancer.
[More]
6. August 2009 06:03
New Cancer Research UK figures out today reveal that stomach cancer cases in Great Britain have dropped by nearly half from around 14,000 in 1975 to 7,485 in 2006.
[More]
4. August 2009 06:54
Heavy drinkers of beer and spirits face a much higher risk of developing cancer than the population at large, says a group of Montreal epidemiologists and cancer researchers.
[More]
615aea43-ba4a-4670-b696-a06c28238828|0|.0
Posted in: Medical Research News
Tags: Cancer, Colon Cancer, Diet, Esophageal Cancer, Liver Cancer, Lung Cancer, Occupational Health, Pancreatic Cancer, Prostate Cancer, Smoking, Stomach Cancer
3. August 2009 12:00
Heavy drinkers of beer and spirits face a much higher risk of developing cancer than the population at large, says a group of Montreal epidemiologists and cancer researchers. Their findings show that people in the highest consumption category increased their risk of developing oesophageal cancer sevenfold, colon cancer by 80% and even lung cancer by 50%.
[More]
1. July 2009 21:49
Vegetarians are 12 per cent less likely to develop cancer than meat eaters, according to new research published in the British Journal of Cancer.
[More]
30. June 2009 03:40
Helicobacter pylori survives in the body by manipulating important immune system cells. This is shown in a thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden. The discovery may lead to new treatments against the common peptic ulcer bacterium.
[More]
24. June 2009 20:24
The National Cancer Intelligence Network (NCIN) and Cancer Research UK has today (Thursday) published the first report on cancer incidence and ethnicity.
[More]